NOT-CA-19-053: Notice of Clarification to RFA-CA-19-032, "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)"

Notice of Clarification to RFA-CA-19-032, "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)"

Notice Number: NOT-CA-19-053

Key Dates
Release Date: June 10, 2019

Related Announcements

RFA-CA-19-032
NOT-OD-15-137

Issued by
National Cancer Institute (NCI)

Purpose

This Notice clarifies and reiterates the necessity for the proposed research to be HIV/AIDS related in RFA-CA-19-032, "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)".

The following text (in italics) has been added to:

Part 2. Full Text of Announcement, Section I. Funding Opportunity Description

Non-Responsive Projects

IMPORTANT NOTE: Applicants uncertain as to whether their intended project meets the requirements of this FOA are encouraged to contact one of the Scientific/Research Contacts listed below in Section VII.

Applicants are encouraged to review the NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html to ensure that their research application(s) is aligned with the NIH Office of AIDS Research Priorities.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Elizabeth L. Read-Connole, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6190
Email: [email protected]